AK
Apparsundaram Kandaswamy
About Apparsundaram Kandaswamy
Data last updated:
Apparsundaram Kandaswamy is a Director at V Clinbio Labs Private Limited (since 2013), Director at Avaca Pharma Private Limited (since 2020) and Director at Vclinbio Pharmaceuticals Private Limited (since 2017). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3 Lakh; the largest is V Clinbio Labs Private Limited at ₹2.4 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 V Clinbio Labs Private Limited U73100TN2013PTC092866 | Director | 05 Sep 2013 | 2013 | ₹2.4 Lakh (FY 2021) | Active |
 Avaca Pharma Private Limited U74999AP2016PTC104239 | Director | 18 Jul 2020 | 2016 | ₹61,895 (FY 2024) | Active |
 Vclinbio Pharmaceuticals Private Limited U74999TN2017PTC114235 | Director | 23 Jan 2017 | 2017 | Active |
Board colleagues of Apparsundaram Kandaswamy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Apparsundram Rajanikanth | 06671547 | V Clinbio Labs Private Limited , Vclinbio Pharmaceuticals Private Limited | Director |
| Subramaniam Apparsundaram | 06671538 | V Clinbio Labs Private Limited | Managing Director |
| Anshul Jain | Avaca Pharma Private Limited | Company Secretary | |
| Mahesh Kandula | 03360152 | Avaca Pharma Private Limited | Director |
| Sridhar Koganti | 07635429 | Avaca Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Apparsundaram Kandaswamy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apparsundaram Kandaswamy
Apparsundaram Kandaswamy currently holds 3 directorships: V Clinbio Labs Private Limited (Director, since 05 Sep 2013, revenue ₹2.4 Lakh (FY 2021)); Avaca Pharma Private Limited (Director, since 18 Jul 2020, revenue ₹61,895 (FY 2024)); Vclinbio Pharmaceuticals Private Limited (Director, since 23 Jan 2017).
Apparsundaram Kandaswamy was first appointed on 05 Sep 2013 as Director at V Clinbio Labs Private Limited. The most recent appointment on record is 18 Jul 2020 at Avaca Pharma Private Limited.
The 2 current companies of Apparsundaram Kandaswamy that report revenue have a combined latest revenue of ₹3 Lakh: V Clinbio Labs Private Limited ₹2.4 Lakh (FY 2021); Avaca Pharma Private Limited ₹61,895 (FY 2024).
The current boards of Apparsundaram Kandaswamy's companies include Apparsundram Rajanikanth (V Clinbio Labs Private Limited), Subramaniam Apparsundaram (V Clinbio Labs Private Limited), Anshul Jain (Avaca Pharma Private Limited), Mahesh Kandula (Avaca Pharma Private Limited), Sridhar Koganti (Avaca Pharma Private Limited).